Welcome to our dedicated page for Certara SEC filings (Ticker: CERT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Certara, Inc. (NASDAQ: CERT) SEC filings page on Stock Titan provides access to the company’s official regulatory documents as filed with the U.S. Securities and Exchange Commission. Certara is a biosimulation and model‑informed drug development company whose common stock is registered on The Nasdaq Stock Market LLC under the symbol CERT, as disclosed in its Form 8‑K filings.
Investors can review current reports on Form 8‑K, which Certara uses to announce material events. Recent 8‑K filings include press releases for quarterly financial results, where the company reports revenue from biosimulation software and services, bookings, and updates to its full‑year financial outlook. Other 8‑K filings document corporate developments such as amendments to the company’s credit agreement and leadership changes, including the appointment of a new chief executive officer.
In addition to 8‑K reports, users can expect to find annual reports on Form 10‑K and quarterly reports on Form 10‑Q (when available), which typically provide more detailed discussions of Certara’s business, risk factors, and financial statements. Filings related to financing arrangements, such as amendments to term loan facilities, are also included and can offer insight into the company’s capital structure and borrowing costs.
Stock Titan enhances these documents with AI‑powered summaries that explain key sections of lengthy filings, helping readers quickly identify important information without reading every page. Real‑time updates from EDGAR ensure that new Certara filings appear promptly, while dedicated sections surface insider transaction reports on Form 4 and other ownership‑related disclosures when they are filed.
By using this page, investors and researchers can follow Certara’s regulatory reporting history, track material events, and better understand how the company describes its biosimulation software, services, and financial performance in official SEC documents.
Certara, Inc. furnished an 8‑K to announce that it issued a press release with financial results for the three-month period ended September 30, 2025. The press release is attached as Exhibit 99.1.
The information provided under Item 2.02 (Results of Operations and Financial Condition), including Exhibit 99.1, is furnished and not deemed “filed” under Section 18 of the Exchange Act and is not incorporated by reference into other filings. The submission also includes Exhibit 104, the Cover Page Interactive Data File (Inline XBRL).
Certara, Inc. amended its credit agreement on October 16, 2025, replacing its existing term loans with new Replacement Term Loans at lower pricing, which is expected to reduce borrowing costs and interest expense.
The loans now bear interest at the borrower’s election of Term SOFR (floor 0.00%) + 2.75% or an ABR (floor 1.00%) + 1.75%. ABR is the greatest of the prime rate, the federal funds effective rate + 0.50%, or Term SOFR + 1.00%. Proceeds were funded in full at closing and used to refinance the prior term loans. Guarantees, collateral, prepayments and covenants remain substantially similar.
Dimensional Fund Advisors LP reported ownership of 8,352,281 shares of Certara Inc. common stock, representing 5.2% of the class as of 09/30/2025. The filing is a Schedule 13G, which indicates a passive investment approach rather than an active effort to influence control. Dimensional discloses it advises multiple Funds that collectively own the shares and expressly disclaims beneficial ownership while noting it has sole voting power over 8,244,677 shares and sole dispositive power over 8,352,281 shares. The signature certifies the holdings were acquired in the ordinary course of business.
Wasatch Advisors LP reported beneficial ownership of 17,398,337 common shares of Certara Inc, representing 10.8% of the class as of the filing event date. Wasatch holds sole dispositive power over all 17,398,337 shares and sole voting power over 12,631,748 shares. The filing identifies Wasatch as an investment adviser organized in Delaware and certifies the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing control. The filing was signed by Wasatch CEO Mike Yeates on 10/07/2025 and lists Certara's principal executive office in Radnor, Pennsylvania.
Leif E. Pedersen, President and Chief Commercial Officer of Certara, Inc. (CERT), reported a sale of 51,224 shares of Certara common stock on 09/09/2025. The sales were effected under a Rule 10b5-1 trading plan adopted on March 5, 2025. The reported weighted-average sale price was $10.92, with individual trade prices ranging from $10.73 to $11.09. After the reported disposition, Mr. Pedersen beneficially owned 73,979 shares, reported as direct ownership. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.
Form 144 filing for Certara, Inc. (CERT): The filer intends to sell 51,224 shares of common stock through Fidelity Brokerage Services on 09/09/2025, with an aggregate market value of $559,303.56. These shares represent restricted stock that vested on 09/09/2020 and were acquired as compensation from the issuer. The company reports 160,623,580 shares outstanding. The filer reports no sales of the issuer's securities in the past three months and includes the standard representation that they are not aware of any undisclosed material adverse information.
Wasatch Advisors LP reported beneficial ownership of 13,532,882 shares of Certara common stock, representing 8.3% of the class. The filer discloses sole dispositive power over all 13,532,882 shares and sole voting power on 9,969,332 shares, and states these securities are held in the ordinary course of business and not for the purpose of changing or influencing control.
This disclosure meets the >5% reporting threshold for institutional investors and notifies the market of a material passive stake in Certara without indicating any plans to seek control.